Follow the chain left → right, from inputs to end demand. Tap any company to trace its links.
Raw inputs
Equipment
Foundry
Chip design
Software
AI demand
—
Company details
Market cap
$23B
P/E ratio
27×
Div yield
1.0%
EPS (TTM)
$10.53
Profit margin
~6%
Rev. growth
+7%
Revenue
$14B
Free cash flow
$1.2B
In plain English
Labcorp is one of the two giant US clinical-lab networks: it runs the blood draw, the assay and the result. Through ~2,200 patient service centres and a fleet of labs it performs hundreds of millions of routine and specialty tests a year for patients and doctors (its Diagnostics business), and it is also the lab behind the drug industry — its Biopharma Laboratory Services arm runs early-development and central-lab testing that supported ~85% of recent FDA drug approvals. It spun off its clinical-trial (CRO) business as Fortrea in 2023 and keeps buying up regional and hospital outreach labs.
In simple terms
What Labcorp really sells
Labcorp is one of the two giant US clinical-lab networks: it runs the blood draw, the assay and the result. Through ~2,200 patient service centres and a fleet of labs it performs hundreds of millions of routine and specialty tests a year for patients and doctors (its Diagnostics business), and it is also the lab behind the drug industry — its Biopharma Laboratory Services arm runs early-development and central-lab testing that supported ~85% of recent FDA drug approvals. It spun off its clinical-trial (CRO) business as Fortrea in 2023 and keeps buying up regional and hospital outreach labs.
Tip · Click any company in the map to learn — in one sentence — what it actually does and why it matters.